About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITINGPhase 2

Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors

Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors: A Randomized Withdrawal Trial

NCT07258160•Second Affiliated Hospital of Soochow University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Solid CancerLymphopenia

Interventions

PRaG-1

Placebo

Locations

1

China

Locations (1)

The Second Affiliated Hospital of Soochow University

Suzhou, Jiangsu, China

Key Dates

Start Date

December 1, 2025

Primary Completion Date

July 1, 2026

Completion Date

September 1, 2026

Last Updated

January 9, 2026

Related Studies

RECRUITINGPhase 1/2

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

NCT07186842

Advanced Solid Cancers

RECRUITINGPhase 1/2

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

NCT05600920

Idiopathic CD4 Lymphopenia

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy

NCT03514368

RECRUITINGPhase 1/2

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

NCT07371663

Solid CancersNSCLC (Advanced Non-small Cell Lung Cancer)+3 more

RECRUITINGEARLY Phase 1

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

NCT07242417

Solid CancerGPC3 Positive Hepatocellular Carcinoma

Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

NCT07161310

Solid CancerNon-Small Cell Lung Cancer+1 more

View all related studies

Contacts

Liyuan Zhang, Doctor

CONTACT

0512-67784829 zhangliyuan126@126.com

Sponsors

Lead Sponsor

Second Affiliated Hospital of Soochow University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions